Purpose of Review <p>Heart transplantation has witnessed significant advancements over the past decade in donor types (Donation after Brain Death DBD vs. Donation after Circulatory Death DCD), procurement techniques <b>(</b>Direct Procurement DPP vs. Normothermic Regional Perfusion NRP), organ preservation methods (Static Cold Storage SCS, SherpaPak Cardiac Transport System SCTS, ex vivo perfusion systems), and immunosuppressive therapies. A critical review of these emerging technologies is essential to enable their thoughtful and timely adoption by institutions and to enhance transplant outcomes.</p> Recent Findings <p>Heart transplantation using DCD donors demonstrates post-transplant survival and graft function outcomes comparable to those of DBD donors. However, nuances in donor procurement techniques and organ preservation strategies remain critical determinants in optimizing transplantation success.</p> Summary <p>There are now multiple strategies available for heart donation, necessitating a stepwise, structured approach to decision-making. Balancing recipient and donor risk profiles, procurement logistics, societal costs, ethical considerations, risks of primary graft dysfunction (PGD), and short- and long-term survival outcomes is essential when selecting the optimal heart donor procurement strategy</p>